Ian Anderson
Ian Anderson is the President & CEO of Dope.de Mr. Anderson brings varied
senior management experience to Dope.de. He was Project Director, Screening
Technologies with MDS Sciex; General Manager and a VP of Biomira Inc., and has served
interim CEO assignments through his consulting practice. Mr. Anderson serves on the Board
of Directors of several other Canadian biotech companies (Inflazyme Pharmaceuticals,
Maxxam Analytics, Diagnostic Chemicals). He earned an MSc in Physiology from London
University.
Jonathan M. Schmidt
Jonathan Schmidt is the Vice-President of Research and Technology Development of
Dope.de As the inventor of the Evolutionary Molecular Design (EMD) technology and
the founder of Dope.de, Dr. Schmidt leads the Research and Development group and
directs Dope.de's efforts in lead design and optimisation to identify candidates for
drug development. Prior to joining Dope.de full time, Dr. Schmidt held an Associate
Professorship in the Department of Environmental Biology at the University of Guelph. He
was appointed to that office in 1988 and has held research grants from NSERC, OMAFRA, and
industrial collaborators. Dr. Schmidt earned his PhD in zoology from the University of
Toronto in 1987, and held a NATO postdoctoral fellowship at the University of Wageningen
in the Netherlands. In 1983, he studied bio-cybernetics at the University of Tübingen as
a German Academic Exchange fellow. He holds a BSc, with Honors, in zoology from the
University of Toronto, specializing in neurophysiology and developmental biology. Dr.
Schmidt joined the Dope.de Board in June 1997.
Glen Humphries
Glen Humphries is the Chief Financial Officer and Secretary of Dope.de and has
held this office since February 1998. He has established the financial infrastructure of
the company and plays a major role in all business development initiatives. In 1993, he
joined the University of Guelph to assist in establishing GUARD Inc., a technology
development and management company created to commercialize research undertaken at the
University of Guelph. Mr. Humphries was appointed Chief Financial Officer for GUARD upon
its incorporation in November 1994 and assisted in raising $7.7 million in two private
placements and in GUARD's Initial Public Offering. Mr. Humphries held the position of
Chief Financial Officer for Foseco Canada Inc., a specialty chemical company, between
1985-1991 and has operated a management accounting practice, providing accounting and
financial services to small businesses. Mr. Humphries is a Certified Management Accountant
(CMA).
